A Technical Word Ahead of Macro Events
Dunkin’ To Be Taken Private By Inspire Brands In $8.8B Deal
Humanigen Treats First Patient in Late-Stage COVID-19 Trial
As the world watches the US election, the appeal of America is diminished
Martenson: We Are Pawns In A Bigger Game Than We Realize
Lauren Wolfe of Impactive Capital presents thesis for HD Supply
The 10 Cities In The Most Financial Distress
Black-Owned Businesses Lead Rebound To Pre-Pandemic Levels
US Dollar Profits from Risk Aversion, Ending October Strong
Market Drops As Traders Head For The Pre-Election Exit 10-31-20
Buckle Up, the Ride may get Bumpy
The Fate Of The Pound Sterling
Is Boeing Stock a Buy Following Q3 Earnings? Analyst Weighs In
Q3 GDP Bounces Back But It’s Not Time to Celebrate
Why Victor Davis Hanson Thinks Trump Will Win
The Crashing Rental Market Could Set Off The Next Housing Crisis
Private Equity Titan Henry Kravis Says In 50 Years He Has Never Seen Markets This Volatile
US COVID-19 Cases Top 9 Million, Belgium Announces 6-Week National Lockdown: Live Updates
10 things we learned at Brookings in October
Week Ahead – Election Time!
Targeting Safe Income? Preferred Stocks Can Help
As COVID-19 cases surge, the country’s economic recovery is losing steam
The (Other) Bull Market That Won't Die
Who Do You Choose, Gold? Trump or Biden?
The COVID/Lockdown Recession Is Over
Regeneron Halts Covid-19 Trial For High-Flow Oxygen Patients; Shares Fall
Hang Seng Index manages a monthly gain on tech strength
Regeneron to stop enrolling very sick Covid-19 patients in antibody trials
September 2020 COVID Update: Americans with disabilities strive to stay in labor market
SARS-CoV-2 might attack red marrow and block new erythrocytes formation